Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Citigroup analyst Scott Gruber downgraded Ovintiv Inc. (NYSE:OVV) from Buy to Neutral and raised the price target from $52 to $62. Ovintiv shares closed at $62.08 on Friday. See how other analysts view this stock.
• Barclays analyst Etzer Darout downgraded Terns Pharmaceuticals, Inc. (NASDAQ:TERN) from Overweight to Equal-Weight and lowered the price target from $56 to $53. Terns Pharma shares closed at $52.92 on Friday. See how other analysts view this stock.
• Wedbush analyst Michael Piccolo downgraded Burford Capital Limited (NYSE:BUR) from Outperform to Neutral and cut the price target from $6 to $4.75. Burford Capital shares closed at $4.14 on Friday. See how other analysts view this stock.
• Raymond James analyst Jayson Bedford downgraded Boston Scientific Corporation (NYSE:BSX) from Strong Buy to Outperform and lowered the price target from $97 to $88. Boston Scientific shares closed at $69.17 on Friday. See how other analysts view this stock.

Considering buying OVV stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.